Catalog No.
YHA30402
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Glu28-Leu398
Predicted molecular weight
59.60 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
O14791
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Apolipoprotein L1, ApoL-I, ApoL, APOL1, APOL, Apolipoprotein L-I, Apo-L, Apolipoprotein L
G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway., PMID:40501951
Robust Serum Proteomic Signatures of APOE2., PMID:40501769
Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study., PMID:40499462
Plasma apolipoprotein concentrations and occurrence of cardiovascular events in the general population: an exploratory analysis., PMID:40485857
Interaction Between Apolipoprotein L1 Genetic Risk and Neighborhood Socioeconomic Status for Kidney Outcomes in a United States Cohort., PMID:40485706
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice., PMID:40459058
Crescentic Glomerulonephritis Possibly Caused by COVID-19 Infection., PMID:40429298
Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer., PMID:40365288
Increased prevalence of coronary heart disease among current smokers carrying APOL1 risk variants within the African American population., PMID:40360375
Late Presentation of Galloway-Mowat Syndrome (GAMOS) Associated With Membranous Nephropathy: A Case Report., PMID:40357071
APOL1 genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIV., PMID:40321250
APOL1 testing in clinical practice and opportunities for new therapies., PMID:40314119
ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease., PMID:40289348
Collapsing Focal Segmental Glomerulosclerosis With Concurrent IgG4 Nephropathy., PMID:40264599
Clinical implications of apolipoprotein L1 testing in patients with focal segmental glomerulosclerosis: a review of diagnostic and prognostic implications., PMID:40213244
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma., PMID:40199156
Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia., PMID:40186439
Kidney disease in patients with HIV., PMID:40184511
A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies., PMID:40125376
Diabetes mellitus and APOL1 genotype increase the risk for chronic kidney disease progression in sickle cell disease., PMID:40112283
[Tissue and plasma proteomic signatures associated with the risk of gastric cancer]., PMID:40107780
A novel signature predicts prognosis in pancreatic cancer based on tumor membrane-associated genes., PMID:40066030
LILRB3 genetic variation is associated with kidney transplant failure in African American recipients., PMID:40065170
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship., PMID:40047214
Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studies., PMID:40038200
Advances in kidney disease: pathogenesis and therapeutic targets., PMID:40027896
APOL1 Dynamics in Diabetic Kidney Disease and Hypertension., PMID:40001508
Platform-dependent effects of genetic variants on plasma APOL1 and their implications for kidney disease., PMID:39975113
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva., PMID:39971436
Multiethnic prevalence of the APOL1 G1 and G2 variants among the Israeli dialysis population., PMID:39927257
Chronic postsurgical inguinal pain: incidence and diagnostic biomarkers from a large German national claims database., PMID:39909798
Association between Apolipoprotein L1 genetic variants and risk of preeclampsia and preterm birth among U.S. Black women., PMID:39895997
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice., PMID:39803526
Genetic Assessment of Living Kidney Transplant Donors: A Survey of Canadian Practices., PMID:39802879
High-selenium exposure is associated with modulation of serum lipid metabolism., PMID:39793284
Collapsing glomerulopathy associated with parvovirus B19 and systemic lupus erythematosus in a patient with APOL1 high-risk variant for nephropathy., PMID:39792859
APOL1 Modulates Renin-Angiotensin System., PMID:39766282
Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes., PMID:39761918
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease., PMID:39747090
Molecular Biomarkers Associated with Traumatic Brain Injury Outcome in Individuals of Black Racial Identity or African Ancestry: A Narrative Review., PMID:39732452
Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database., PMID:39729127
Emerging role of genetics in kidney transplantation., PMID:39710162
The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event., PMID:39658338
Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study., PMID:39624929
G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area., PMID:39616492
Effect of fetal apolipoprotein L1 genotype and vitamin D deficiencies on preeclampsia risk., PMID:39579687
Has APOL1 kidney disease treatment been hiding in plain sight?, PMID:39577983
Adipocytes reprogram the proteome of breast cancer cells in organotypic three-dimensional cell cultures., PMID:39505903
Surrogate End Points in Apolipoprotein L1 - Associated Kidney Disease : Evaluation in Three Cohorts., PMID:39499577
African-Colombian woman with preeclampsia and high-risk APOL1 genotype: A case report., PMID:39496047
For research use only. Not for human or drug use.
